Recipharm Strengthens Clinical-to-Commercial OSD Pipeline with Spain Investment
Recipharm, a leading global contract development and manufacturing organisation (CDMO), announced a strategic investment to further strengthen its high potency oral solid dose (OSD) capabilities at its Leganés site in Spain. The new high potency clinical and pilot capabilities, scheduled to be operational by the end o…
